These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5611331)

  • 1. [Use of Atromid in the treatment of patients withcoronary artherosclerosis].
    Zadionchenko VS
    Sov Med; 1967 Jan; 30(1):77-81. PubMed ID: 5611331
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of anticoagulants in ambulatory patients in the complex treatment of patients and the prevention of atherosclerotic lesions of the coronary vessels].
    Nazardinov FV; Kazimiorva KI
    Sov Med; 1967 May; 30(5):146. PubMed ID: 5612986
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary artherosclerosis: a medical or a surgical future?
    Withering W
    J Med Assoc Ga; 1972 Feb; 61(2):52-4. PubMed ID: 4670661
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cocarboxylase treatment of patients with ischemic heart disease and several other diseases].
    Egorov MN; Nozdriukhina LR; Pastukhova NP; Zhuravleva VI; Pisarskaia IV
    Ter Arkh; 1967 Feb; 39(2):91-3. PubMed ID: 5611695
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of cetamiphen in patients with coronary arteriosclerosis].
    Savenkov PM
    Sov Med; 1966 Apr; 29(4):98-100. PubMed ID: 5984051
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood lipids in normal subjects, coronary artherosclerosis and aged].
    MOSSO HE; KAPLAN SJ
    Prensa Med Argent; 1956 Oct; 43(40):3031-7. PubMed ID: 13419912
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of the fibrinolytic activity of dimethylbiguanide in prevention of thromboembolism in patients with angiocardiopathy].
    Molino N; Belluardo C
    Rass Int Clin Ter; 1968 Jun; 48(11):687-700. PubMed ID: 5738544
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of Atromid S on lipid metabolism in coronary insufficiency].
    Gabryś B; Konturek S; Keita-Fyda A
    Pol Tyg Lek; 1968 Oct; 23(42):1608-10. PubMed ID: 5702858
    [No Abstract]   [Full Text] [Related]  

  • 9. [Electroencephalographic findings in a group of aged subjects treated with potentiated gerovital-H3].
    Aslan A; Buşilă V; Sacerdoţeanu F
    Fiziol Norm Patol; 1968; 14(3):263-70. PubMed ID: 5686658
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thiadenol in the short-term treatment of patients with blood lipid disorders].
    Di Stefano F; Patane S; Gatto A
    Minerva Med; 1980 Mar; 71(8):567-74. PubMed ID: 7360386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of vitamin E on the blood serum histamine content and histaminase activity in coronary arteriosclerosis].
    Allianova LN
    Vrach Delo; 1982 Jun; (6):61-4. PubMed ID: 6810551
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of atherosclerosis with hypolipidemic and antiuricemic agents].
    Plastinina RA; Oleĭnik NA; Valeeva RM; Pavlova TN
    Sov Med; 1984; (1):83-7. PubMed ID: 6701660
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of arteriosclerotic vasculopathies with arterial wall extract].
    Veccia F
    Clin Ter; 1967 Sep; 42(5):429-42. PubMed ID: 5617689
    [No Abstract]   [Full Text] [Related]  

  • 14. [Behavior of the lipid spectrum of the blood, particularly of polyunsaturated fatty acids in the course of therapy with an indirect anticoagulant].
    Facchini G; Pannuti F; Ghironzi GC; Rapino P
    Arch Patol Clin Med; 1965 Jun; 41(6):401-22. PubMed ID: 5835862
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipids and their role in coronary heart disease: what they do and how to manage them.
    Pradka LR
    Nurs Clin North Am; 2000 Dec; 35(4):981-91. PubMed ID: 11072283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the use of an association of ATP, cocarboxylase and beta-hydroxy-propyl-theobromine in cardiovascular therapy].
    Alberto S; Brusasco L; Colongo PG
    Minerva Cardioangiol; 1966 Sep; 14(9):557-63. PubMed ID: 5991009
    [No Abstract]   [Full Text] [Related]  

  • 17. [Necessity of hypolipemic treatment in patients with coronary disease].
    Fernández-Miranda C; Aranda IL
    Med Clin (Barc); 1999 Mar; 112(11):438. PubMed ID: 10231779
    [No Abstract]   [Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
    Yu J; Jin N; Wang G; Zhang F; Mao J; Wang X
    Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of treatment with chorionic gonadotropins on the electrocardiograms of patients with arteriosclerotic coronary disease and those with hypertensive heart diseases].
    Palma A; Guglielmotti A
    Rass Int Clin Ter; 1968 Apr; 48(7):396-415. PubMed ID: 5738538
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences with hexobendine in coronary disease].
    Eral N
    Arzneimittelforschung; 1968 Aug; 18(8):1094-103. PubMed ID: 5755844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.